Image source: Shutterstock

Highlights

  • AMS reported an 8% YoY revenue increase to GBP 68.0 million in 1H2024
  • Adjusted profit before tax rose 7.2% in the first half of 2024, reaching GBP 14.8 million with a stable margin
  • AMS forecasts full-year 2024 revenues of GBP 177 million and adjusted pre-tax profit of GBP 29.2-29.7 million.

Advanced Medical Solutions Group PLC (LSE:AMS) is a UK-based independent company listed on the FTSE AIM UK 50 Index. It specializes in developing and manufacturing innovative tissue-healing technologies, with a strong focus on delivering high-quality outcomes for patients.

AMS reported an 8% YoY increase in revenue, reaching GBP 68.0 million in 1H2024, compared to GBP 63.1 million in 1H2023 (10% at constant currency). This growth was driven by positive results across all categories in the Surgical Business Unit, although challenges in the Woundcare Business Unit partially offset the gains.

Adjusted profit before tax saw a 7.2% rise in 1H2024, reaching GBP 14.8 million (up from GBP 13.8 million in 2023), with a stable margin of 21.8%.

However, during the reported period, profit before tax declined to GBP 5.7 million, down from GBP 11.8 million in H1 2023, due to significant acquisition-related exceptional items incurred during the period.

Recent Business Update

AMS' full year 2024 trading update highlights significant progress after acquiring Syntacoll and Peters Surgical, with strong growth across surgical product categories. Strategic initiatives in the Woundcare are expected to boost margins in 2025. The Group forecasts revenues of GBP 177 million and adjusted pre-tax profit of GBP 29.2 - 29.7 million. Full Year result is slated to be announced on 19 March 2025.

Top 10 Shareholders

The top 10 shareholders of AMS together account for approximately 49.98% of the company's total shares. Octopus Investments Limited is the largest shareholder, holding around 12.99%, while Rathbone Unit Trust Management Limited follows with a shareholding of approximately 9.56%.

 Stock Information

AMS' stock price has increased by approximately 6.17% over the past month, although it has experienced a decline of about 13.16% over the past six months. The stock's 52-week range is between a low of GBX 176.60 and a high of GBX 275.83, and it is currently trading below the average of this range. As of 5 February 2025, the stock was last priced at GBX 204.50.

Note 1: Past performance is not a reliable indicator of future performance.
Note 2: The reference data for all price data, currency, technical indicators, support, and resistance levels is 05 February 2025. The reference data in this report has been partly sourced from EODHD/Others.